Italian lawyers fear French UPC ‘landgrab’

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Italian lawyers fear French UPC ‘landgrab’

Europe viewed from space at night with city lights in European Union member states, global EU business and finance, satellite communication technology, 3D render of planet Earth, world map from NASA

Milan may only fulfil its UPC dream at a price, with a decision from negotiations between France and Germany expected shortly

Italian lawyers fear Milan’s potential Unified Patent Court central division will miss out on key pharmaceutical cases if talks with France and Germany result in some life sciences cases being heard in Paris.

A spokesperson for Germany’s Ministry of Justice (MoJ) confirmed to Managing IP yesterday, March 13, that trilateral discussions with Italy and fellow UPC central division host France were ongoing and that a decision is expected “shortly”.

Milan is the only contender to host the third central division seat, which was originally assigned to London before the UK quit the UPC project in 2020.

The London division was expected to specialise in life sciences cases.

The other two central seats are in Paris and Munich.

Italy bid for Milan to replace London on the basis that its division would assume responsibility for life sciences cases.

However, a report in the Italian newspaper Il Sole 24 Ore last month said that the original allocation of cases to the different central divisions was under debate.

France and Germany have, according to that report, proposed that the Paris division should hear cases involving pharmaceutical patents for which a supplementary protection certificate (SPC) is in effect.

That would leave the proposed Milan division with non-SPC pharma cases, a prospect that has alarmed some Italian practitioners who campaigned for Milan to host the seat.

Laura Orlando, joint global head of IP at Herbert Smith Freehills in Milan, said the rumoured proposal appeared to be a “landgrab” with no legal basis.

She added that a split between SPC and non-SPC cases would be entirely arbitrary and impractical from an enforcement perspective.

“This new debate on the competence of the third central division appears to stem from purely political considerations, which worryingly do not take into account the technical and legal context,” Orlando told Managing IP.

But while the Italian legal sector has reacted mostly negatively to the proposal, some practitioners think a compromise might be worthwhile.

Roberto Valenti, partner at DLA Piper in Milan, said a compromise on SPC cases would be worth it if the Milan division could start hearing cases from when the UPC opens in June.

“The third central division is extremely important, not only for Italy but for the system as a whole.

“I hope parties agree on a solution now rather than later,” Valenti said.

A spokesperson for Germany’s MoJ said the establishment of a central division in Milan would require an amendment to the UPC Agreement (UPCA), which still references London.

Munich and Paris will temporarily assume all central division responsibilities if no deal to amend the UPCA has been reached by the time the court opens on June 1, she added.

more from across site and SHARED ros bottom lb

More from across our site

The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Gift this article